BE901433A - STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME. - Google Patents

STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME.

Info

Publication number
BE901433A
BE901433A BE1/11164A BE1011164A BE901433A BE 901433 A BE901433 A BE 901433A BE 1/11164 A BE1/11164 A BE 1/11164A BE 1011164 A BE1011164 A BE 1011164A BE 901433 A BE901433 A BE 901433A
Authority
BE
Belgium
Prior art keywords
ketosis
preparing
treatment
pharmaceutical composition
same
Prior art date
Application number
BE1/11164A
Other languages
French (fr)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of BE901433A publication Critical patent/BE901433A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Cette composition qui comprend du propionate de calcium, de la dextrose et du propylène glycol, se caractérise en ce que ce dernier est lié à un support solide consistant en oxyde de magnésium, carbonate de magnésium, peroxyde de magnésium et/ou silice, la quantité de support étant dans la gamme de 33 à 300 % en poids par rapport au propylène glycol.This composition which comprises calcium propionate, dextrose and propylene glycol, is characterized in that the latter is linked to a solid support consisting of magnesium oxide, magnesium carbonate, magnesium peroxide and / or silica, the amount of support being in the range of 33 to 300% by weight relative to propylene glycol.

BE1/11164A 1984-01-06 1985-01-03 STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME. BE901433A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8440A HU191245B (en) 1984-01-06 1984-01-06 Process for the production of stbale pharmaceutical preparation against ketosis

Publications (1)

Publication Number Publication Date
BE901433A true BE901433A (en) 1985-07-03

Family

ID=10947613

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/11164A BE901433A (en) 1984-01-06 1985-01-03 STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME.

Country Status (6)

Country Link
JP (1) JPS60214747A (en)
BE (1) BE901433A (en)
DE (1) DE3500187A1 (en)
FR (1) FR2565105B1 (en)
GB (1) GB2153670B (en)
HU (1) HU191245B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202742B (en) * 1987-03-26 1990-11-28 Univ London Preventing adp-ribosylation of g-proteins
JP3230814B2 (en) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション Magnesium carbonate and oil tablet forming aid
US5601836A (en) * 1993-06-28 1997-02-11 Great Lakes Biochemical Company, Inc. Nutritional supplement for calving ruminant animals
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
CA2283802C (en) 1997-03-21 2006-05-09 Basf Aktiengesellschaft Propionic acid, ammonia, propanediol and water solutions and the use thereof
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
CN104922064B (en) * 2015-05-28 2019-01-29 广东温氏大华农生物科技有限公司 A kind of nanoscale nutrient microemulsion and preparation method thereof for preventing and treating ketosis of dairy cows

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156999C (en) * 1902-04-02
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
FR1546819A (en) * 1967-01-14 1968-11-22 Union Agricole Ag Fuer Landw S Process for supplemental feeding of high-yield dairy cows, in particular before and after calving, and supplemental feed for the implementation of the process
US3621163A (en) * 1970-01-19 1971-11-16 Acb Corp Inertia switch
DE2014844C2 (en) * 1970-03-26 1984-09-06 Boliden Ab, Stockholm Process for the manufacture of a granulated magnesium oxide product
DE2518189A1 (en) * 1975-04-24 1976-11-04 Astra Ewos Ab Trace element concentrate for animal feeds - heavy mineral substance coated with binder which contains trace elements
SE421042B (en) * 1976-06-29 1981-11-23 Kockums Chem WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT
JPS5344636A (en) * 1976-10-05 1978-04-21 Mitsubishi Chem Ind Ltd Remedy and prevention for milk fever
GB1596505A (en) * 1976-11-23 1981-08-26 Unilever Ltd Food manufacture
DE3010250A1 (en) * 1980-03-17 1981-09-24 Wolf Freiherr von 8183 Rottach-Egern Tucher Animal e.g. pig feed pre:concentrate - to reduce odour of animal excrement contg. a poly:hydric alcohol, a saturated fatty acid and a carrier
AT372854B (en) * 1981-02-03 1983-11-25 Moser Siegfried Dr METHOD FOR PREVENTING THE DEVELOPMENT OF ENGRAVING HEALTH INTERFERENCE IN RETURNS AND FOR PREVENTING DEER BITE
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU190866B (en) * 1984-01-06 1986-11-28 Egis Gyogyszergyar,Hu Process for producing concentratum increasing the weight output and containing agent of 1-25 mass pct. and/or animal food containing agent of 0,001-0,075 mass pct.

Also Published As

Publication number Publication date
GB8500143D0 (en) 1985-02-13
JPH0324450B2 (en) 1991-04-03
FR2565105B1 (en) 1988-07-01
HUT37336A (en) 1985-12-28
GB2153670A (en) 1985-08-29
GB2153670B (en) 1988-03-23
DE3500187A1 (en) 1985-07-18
HU191245B (en) 1987-01-28
JPS60214747A (en) 1985-10-28
FR2565105A1 (en) 1985-12-06

Similar Documents

Publication Publication Date Title
OA06914A (en) Process for the preparation of substituted iminodiacides.
ES272001U (en) Split pulley.
DE3764816D1 (en) SHOWING COUPLES, H2-ANTAGONISTS OF SHOWING MIXTURES CONTAINING HISTAMINE AND METHOD FOR THE PRODUCTION THEREOF.
BE1003021A3 (en) PHARMACEUTICAL COMPOSITIONS ACTING PARTICULARLY ON THE CARDIAC AND CARDIOVASCULAR SYSTEM AND PROCESS FOR PREPARING THE SAME.
BE901433A (en) STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF KETOSIS AND METHOD FOR PREPARING THE SAME.
DK315082A (en) CLEANING ALUMINUM SILICATE BUILDER AND LOW PHOSPHATE CONTENT
OA06973A (en) Process for the enzymatic preparation of 2-amino-4-methylphosphino-butiryque- (L) acid.
BE822843A (en) METHOD AND AGENT FOR THE ACTIVATION OF CHOLESTERIN OXIDASE
FR2438024A1 (en)
FR2364228A1 (en) PROCESS FOR PREPARING A TITANIUM TRICHLORIDE CATALYST USED
OA07984A (en) Stereocontrolled process for the preparation of acetoxyazetidione.
AU542960B2 (en) Non irritating tetramisole or levamisole pour on compositions
OA06792A (en) Process for the preparation of ester derivatives of cyclopropane-carboxylic acids.
OA06940A (en) Process for the preparation of an inocolum for the maintenance of septic tanks and the like, comprising dehydrated microorganisms and enzymes and inocula prepared by this process.
CA1262140C (en) 7-oxabicycloheptane substituted prostaglandin alcohols
OA06525A (en) Preparation of hydroxylated derivatives of isopropylamino-pyrimidine (oxygen reduction sequence).
FR2642423B1 (en) PROCESS FOR THE PREPARATION OF PURIFIED FATTY ALKYLDIETHANOLAMIDES, THE PRODUCTS OBTAINED AND THEIR USES
SU694557A1 (en) Steel
GB2072661B (en) Saltgs of mixed esters for use as water dilutable metal-working lubricants
GR75173B (en)
BE894228A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS
FR2392047A1 (en) POLYMERISABLE MIXTURE OF METHYLVINYLBENZENES ISOMERS
ES2014445B3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 5-PHENYL-1,3-DIOXIALKENYLIC COMPOUNDS.
BE901435A (en) FODDER CONCENTRATE INCREASING WEIGHT GAIN.
OA06793A (en) Process for the preparation of ester derivatives of cyclopropane-carboxylic acids.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EGYT GYOGYSZERVEGYESZETI GYAR

Effective date: 19970131